SPL starpharma holdings limited

DEP Enrollment Update

  1. WBA
    2,587 Posts.
    lightbulb Created with Sketch. 477
    DEP Updates from AGM Presentation November 2020.

    • DEP docetaxel - Was 37 now 40 (+3) - Not sure what trial figures are said to be for phase 2.
    • DEP cabazitaxel - Was 17 with phase 2 first stage trail participant aim of 30 - Now 35 (+18) - appears over and above aim
    • DEP Irinotecan - Phase 2 was 27 now 40 +13 - Not sure on population target

    Appears to me that recruitment has gone well and at least one trial is fully recruited, anyone else have views on enrollment numbers please?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.2¢
Change
0.005(5.75%)
Mkt cap ! $38.47M
Open High Low Value Volume
8.9¢ 9.2¢ 8.9¢ $8.575K 94.37K

Buyers (Bids)

No. Vol. Price($)
1 93256 9.0¢
 

Sellers (Offers)

Price($) Vol. No.
9.2¢ 43400 2
View Market Depth
Last trade - 16.10pm 03/07/2025 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.